Traumatic Segment to Grow Significantly During 2021-2028

According to our latest study on ""Single-Use Negative Pressure Wound Therapy Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Wound Type, and End User,"" the market is expected to grow from US$ 498.3 million in 2021 to US$ 892.3 million by 2028; it is estimated to grow at a CAGR of 8.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors governing the market's growth.

Increasing prevalence of wounds, owing to various conditions such as burns, trauma, and surgery, rising demand for effective wound management, and increasing technological advancements are likely to fuel the market's growth. However, the complications such as infection, bleeding, and discomfort associated with single-use negative pressure wound therapy devices may hinder the market's growth.

Rising Funding Allocation to Surgery in Low and Middle-Income Countries

Advances in wound care technology have been found to help in healing and patient satisfaction. Negative pressure has long been associated with high-cost care and has only been used in secondary care. Negative pressure is becoming more popular in the community, and it could benefit both the patient and the service by offering high-quality care at the patient's home. There is also a growing demand for treating patients with complex wounds in the community, and community-based NPWT is expected to become more prevalent. Early data analysis revealed that covering complex wounds would cost substantially less than using standard bandages, resulting in higher expenses due to extra nurse visits. Improved surgical access could prevent most of the morbidity and death associated with surgical disorders in low- and medium-income countries (LMICs). Approximately 5 billion people lack access to safe, inexpensive, and timely surgical care; this situation is exacerbated in LMICs, where nine out of ten people lack basic surgical care.

Financial assistance for global health has increased dramatically during the last 15 years. Private philanthropic organizations provide most US funding, which is typically narrowly targeted and does not always reflect local needs or promote capacity building. Improving surgical treatment and integrating it into national health systems in LMICs will almost certainly necessitate more financial resources. Tracking surgical money helps quantify and clarify current investments and funding shortfalls, ensuring that promises are kept, and encourages transparency in global health spending. According to BMJ Open, in 2016, US$ 31.6 billion was allocated to health-related development assistance (DAH). One of the projects was creating a low-cost negative pressure wound therapy system for LMICs. The second was the National Eye Institute's (NEI) long-term contribution to the World Health Organization's (WHO) Prevention of Blindness initiative.

Therefore, the rising funding allocation to surgery in low and middle-income countries would offer significant opportunities for the single-use NPWT devices market during the forecast period.

Wound Type-Based Insights

Based on wound type, the single-use negative pressure wound therapy devices market is segmented into surgical, ulcers, traumatic, burns, flaps & grafts, sports injury, and burns. The traumatic segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period.

End User-Based Insights

Based on end user, the single-use negative pressure wound therapy devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. In 2021, the hospitals segment held the largest share of the market. However, the dermatology clinics segment is expected to register the highest CAGR in the single-use negative pressure wound therapy devices market from 2021 to 2028.

Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann & Rauscher GmbH & Co. KG; Medela AG; Mölnlycke Health Care AB; Paul Hartmann Ag; and Smith & Nephew plc are among the leading companies operating in single-use negative pressure wound therapy devices market.

The report segments the single-use negative pressure wound therapy devices market as follows:

Based on wound type, the single-use negative pressure wound therapy devices market is categorized into surgical, ulcers, traumatic, burns, flaps & grafts, sports injuries, and burns. By end user, the single-use negative pressure wound therapy devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. Based on geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id:sales@premiummarketinsights.com